Roles of roflumilast, a selective phosphodiesterase 4 inhibitor, in airway diseases

Journal of Thoracic Disease
Theerasuk Kawamatawong

Abstract

Asthma and chronic obstructive pulmonary disease (COPD) are common chronic respiratory diseases. Both diseases have incompletely distinct pathophysiology, clinical manifestation, and treatment responsiveness. Pulmonary and systemic inflammations are the hallmarks of COPD. Most asthma responds to inhaled corticosteroid (ICS) treatment. In contrast, COPD is a corticosteroid-resistant disease. Bronchodilators are a preferred treatment method of COPD, with the aim of improving symptoms and preventing exacerbation. In addition, corticosteroid insensitivity is an underlying mechanism in severe asthma. An overlap of features between asthma and COPD, which was described as asthma-COPD overlap syndrome (ACOS) is not uncommon in practice. Novel nonsteroidal therapies focusing on inflammation in asthma and COPD have been developed. Selective phosphodiesterase 4 (PDE4) inhibitor is a promising class of drugs that has been studied for the treatment of COPD. Selective PDE4 inhibitor is different from xanthine in terms of mechanisms and pharmacokinetic profiles. This review focuses on clinical data on PDE4 inhibitors and its future roles in asthma, COPD, bronchiectasis, ACOS and other chronic non-pulmonary diseases.

Citations

Sep 23, 2018·Respirology : Official Journal of the Asian Pacific Society of Respirology·Kate H Regan, Adam T Hill
Nov 6, 2018·Frontiers in Pharmacology·Heng LiWei Tang
Jan 27, 2019·Expert Opinion on Investigational Drugs·Polyxeni NtontsiGeorgios Hillas
Jan 7, 2019·European Journal of Medicinal Chemistry·Priscila Baltazar Gonçalves, Nelilma Correia Romeiro
Mar 21, 2021·Current Opinion in Pharmacology·Ankush SharmaSolomon Habtemariam
Mar 25, 2021·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Basel A Abdel-WahabEmad H M Hassanein
Jul 3, 2021·Pulmonary Pharmacology & Therapeutics·Junichiro KawagoeKazutetsu Aoshiba
Jul 17, 2021·The Journal of Nutritional Biochemistry·Minh Tan PhamChun-Ming Huang
Jul 31, 2021·Pharmacology Research & Perspectives·Xiao-Fang ZhengJin-Nong Zhang
Aug 18, 2020·International Journal of Pharmaceutics·Érika Yoko SuzukiValeria Pereira de Sousa
Aug 27, 2021·Frontiers in Pharmacology·Theerasuk Kawamatawong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

© 2022 Meta ULC. All rights reserved